ADC Review (@ADCReview) header
ADC Review (@ADCReview) profile picture

ADC Review/J. Antibody-drug Conjugates, an open access journal, brings together researchers, scientists and physicians involved in the growing field of ADCs.

Phoenix, AZ (USA)
Joined March 2013
The @OncoZine Brief with Peter Hofland on @ukhealthradio - Dr. Heery MD, medical oncologist with expertise in the translational & clinical development of #immunotherapies & Dr. Verstovsek about the developments in treatment of myeloproliferative neoplasm. bit.ly/3K9XFzF
1
5
1
170
The @OncoZineBrief with Peter Hofland on @ukhealthradio - Dr. Matthias Bucerius, Vice President & General Manager at @merckgroup - Helping its clients in developing & manufacturing a variety of products, including antibody-drug conjugates. 👉🏼 🎧 bit.ly/3TD2Zix
5
2
162
ADC Review retweeted
In this @OncoZine Network article, #Certara expert Dr. Julie Bullock discusses how to prepare for success through Project Optimus, an initiative to reform dose optimization and dose selection paradigm in oncology #drugdevelopment. Read it here: ow.ly/teUx50LjoEF
6
5
Dhruvajyoti (Dhruv) Roy, PhD @heliogenomics joins the @OncoZine editorial advisory board prn.to/3wguLXs
6
1
ADC Review retweeted
Meet Novasep at the 13th World ADC - September 6 -9 -- Booth #54 - adc.expert/NovasepWADCSepSD2… @World_ADC @Novasep @Oncozine #Oncology @pharmazell #adcc #Cancer #pharma #CDMO
1
2
Lynch Syndrome affects 1/300 people, but only 5% of cases are diagnosed. Listen how @TridentDMG client @AmbryGenetics is making a difference in cancer prevention and early diagnosis with genetic testing in a new episode of the @OncoZine Brief. open.spotify.com/episode/5qD…
3
2
ADC Review retweeted
While #ASH21 has officially ended, don't forget all the great binge watching opportunities you have on the virtual platform & the virtual ASH Poster Walks happening on Dec. 15 and 16! &, of course, mark your calendars for #ASH22 in New Orleans 🥳🎉
7
28
2
96
ADC Review retweeted
Sacituzumab Govitecan Receives European Marketing Authorization for the Treatment of mTNBC in Second Line adcreview.com/news/sacituzum… via @adcreview
ADC Review retweeted
The latest updates about Breast Cancer research in ADC Review | Journal of Antibody-drug Conjugates - adcreview.com #BreastCancerAwareness #CancerDeMama #CancerResearch #cancercare #adc
2
1
[ASAP] Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody–Drug Conjugates dlvr.it/S8X37G
1
1
Sterling Pharma Solutions experiences record US growth ow.ly/KG3430jL1pd
adc.expert/Vic-TrastuzumabDu… Phase III TULIP® study with [vic-]trastuzumab Duocarmazine (SYD985; @Byondis) meets primary endpoint Biopharmaceuticals), #cancer #oncology #breastcancer #adc #clinicaltrials #research #breastcancer @AACR #antibodydrugconjugate @ASH_hematology @ASCO
This week in The Onco’Zine Brief: Peter Hofland, Ph.D. talks with Tony Polverino, Ph.D. In the program, Hofland asks Polverino about his work at Zymeworks. adc.expert/Zymeworks-2021-Ma… @AACR @ASCO #ASCO21 #cancerresearch #ADC #drugdevelopment @ZymeworksInc
Peter DeYoung, CEO, Piramal Global Pharma, shares his thoughts on @PiramalPharma’s acquisition of Hemmo Pharma and what this means to our organization. #PiramalPharma #HemmoPharma #Pharmaceutical
2
12
From testing toxicity to payload selection, what’s the biggest challenge in developing #antibodydrugconjugates? Experts discussed their developments in #ADC technology at #AntibodyEng. spr.ly/6012y6oFy
1
2
ADC Review retweeted
This session with Sara A. Hurvitz, MD, FACP, is designed to help physicians assess the latest available data on antibody-drug conjugates that target HER2/3 overexpression in breast, gastrointestinal, and lung cancers. Register now: bit.ly/3uJx82l #FutureofOncologyNOW2021
1
1
1
WuXi Bio steps up its ADC manufacturing game with a new, dedicated subsidiary! Along with WuXi STA, WuXi Biologics of Shanghai, created a new subsidiary which will focus on the production of antibody-drug conjugates! #healthcare #CDMO #China bit.ly/3hSuxzl
1
4
Small molecule impurities can be a significant challenge when designing control systems during therapeutic manufacture of #antibody drug conjugates. Here’s what you need to know to ensure these impurities are controlled and minimized: bit.ly/3uhvOCw #biologics #ADC
1
3
I just started following @ADCReview on #Vimeo: vimeo.com/adcreview